Owl Tri State Pharmacy (Chastains, Inc.), Clarkston, WA

Is Owl Tri State Pharmacy (Chastains, Inc.) registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does Owl Tri State Pharmacy (Chastains, Inc.) hold a Washington pharmacy license?

State board of pharmacy records for Washington are not checked: the Department of Health’s open dataset on data.wa.gov lists individual credentials but not pharmacy licenses, and its enforcement column has been removed for now; the department’s provider search is an interactive search, which this index does not use.

Has Owl Tri State Pharmacy (Chastains, Inc.) had a state board action or FDA letter?

FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 state referral letter (Jan 21, 2022) and 1 FMD-145 letter (Jan 21, 2022) for Owl Tri State Pharmacy (Chastains, Inc.). State board of pharmacy records for Washington are not checked: the Department of Health’s open dataset on data.wa.gov lists individual credentials but not pharmacy licenses, and its enforcement column has been removed for now; the department’s provider search is an interactive search, which this index does not use. The state referral and handoff letters above are FDA’s letters to the state, not board actions.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
Chastains, Inc.; Owl Tri State Pharmacy
Location
Clarkston, WA
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
1
Warning letters on FDA’s actions page
0
Latest action on that page
Jan 21, 2022
FDA Data Dashboard inspections
1 inspection: 1 VAI; 1 published Form 483
Form 483 text on this page
1 Form 483, 1 observation
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Chastains, Inc., (dba Owl Tri State Pharmacy), a 503A facility, with 3 dated actions.

Document
Jan 21, 2022FMD-145 letterFMD-145 Letter Issued 01/21/2022Not linked by FDA
Jan 21, 2022State referral letterState Referral Letter Issued 01/21/2022Not linked by FDA
Aug 27, 2021Form 483483 Issued 08/27/2021FDA copy (archived)

A Form 483 lists investigator observations, not a final FDA determination. An untitled or FMD-145 letter states FDA’s view when it was issued.

FDA inspection classifications and published Form 483s

The FDA Data Dashboard, read Nov 15, 2026, lists Chastains Inc., Clarkston, WA (FEI number 1000107122), matched to this page by exact name, city and state. It lists 1 inspection: 1 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.

Inspection endedClassificationProject area and product typeFEIInspection ID
Aug 27, 2021Voluntary Action Indicated (VAI)Drug Quality Assurance (Drugs)10001071221149956

Form 483s FDA has published for this site

FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.

Form 483 observations

A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.

FDA’s published Form 483 for this site has 1 numbered observation in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.

Inspection Aug 23, 2021 to Aug 27, 2021: 1 observation

Firm on the cover
Chastains Inc. dba Owl Tri State Pharmacy, 1275 Highland Ave, Clarkston, WA 99403-2846
FEI number
1000107122
Establishment type on the cover
Producer of Non-Sterile Drug Products
FDA district office on the cover
22215 26th Ave SE Suite 210 Bot hell, WA 98021
Matched to this page by
FEI number on the cover; linked from actions page, Data Dashboard
FDA document
Read the full 483 (PDF on fda.gov)

Observation 1

Non-microbial contamination was observed in your production area.

Specifically,

a. Glassware beakers and mortars that were considered clean and stored in the clean glassware shelves were dirty, had grease, or corrosion stains. Dirty glassware was observed to be used for non-hazard and USP-800 hazardous drug production.

b. An air vent and ceiling grids above the entrance to the USP-800 lab and non-hazard lab, and above the <Redacted B4> dispenser machine had large pieces of dust hanging. This was right in front of the two compounding labs. The top of the <Redacted B4> dispenser machine was covered with copious amounts of dust.

5 4 c. <Redacted B4> sinks in the pharmacy area and <Redacted B4> in each production lab had corrosion stains. The linoleum floor around the sink of the non-hazard lab w as heavily soiled and had open gaps w here it was not sealed closed to the wall.

d. Some apparent chemical residue was observed around the base of the <Redacted B4> hood in the non-hazard lab and around the analytical balance. The residue was observed visually and with the use of a UV light. ...

Read the full 483 (PDF on fda.gov)

State board of pharmacy records

State board of pharmacy records for Washington are not checked: the Department of Health’s open dataset on data.wa.gov lists individual credentials but not pharmacy licenses, and its enforcement column has been removed for now; the department’s provider search is an interactive search, which this index does not use.

This page restates FDA’s lists. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.